Matthew Clark DO
Article
Evidence for Reduced-Dose DOAC in Those at High Risk for VTE Recurrence in Extended Phase Anticoagulation: The RENOVE Trial
June 2, 2025
Clinical question: Is extended-phase anticoagulation with dose-reduced direct oral anticoagulants (DOACs) as effective and safe as full-dose DOACs in those with venous thromboembolism (VTE) at high...
Article
Statins should be continued in hospitalized patients with COVID-19
May 2, 2022
Clinical question: Does discontinuation of atorvastatin in those hospitalized with COVID-19 change the risk of mortality and ventilation? Dr. Clark Background: Statins are ubiquitous. Statins...